Clinical Trial: Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS

U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07197944) titled 'Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS' on Sept. 26.

Brief Summary: The purpose of the present Phase 3 trial is to confirm the efficacy and safety of glepaglutide 10 mg twice weekly in a patient population with SBS-IF and generate additional long-term safety data.

Glepaglutide is the International Nonproprietary Name and United States Adopted Name (USAN) for ZP1848.

Study Start Date: Oct. 23

Study Type: INTERVENTIONAL

Condition: Short Bowel Syndrome

Intervention: DRUG: Glepaglutide

Subcutaneous (SC) injections twice weekly

OTHER: Placebo

SC injections twice weekly

Recruitment Status: NOT_YET_REC...